Author:
Hirano Makito,Kuwahara Motoi,Yamagishi Yuko,Samukawa Makoto,Fujii Kanako,Yamashita Shoko,Ando Masahiro,Oka Nobuyuki,Nagano Mamoru,Matsui Taro,Takeuchi Toshihide,Saigoh Kazumasa,Kusunoki Susumu,Takashima Hiroshi,Nagai Yoshitaka
Abstract
AbstractCerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) has recently been attributed to biallelic repeat expansions in RFC1. More recently, the disease entity has expanded to atypical phenotypes, including chronic neuropathy without cerebellar ataxia or vestibular areflexia. Very recently, RFC1 expansions were found in patients with Sjögren syndrome who had neuropathy that did not respond to immunotherapy. In this study RFC1 was examined in 240 patients with acute or chronic neuropathies, including 105 with Guillain-Barré syndrome or Miller Fisher syndrome, 76 with chronic inflammatory demyelinating polyneuropathy, and 59 with other types of chronic neuropathy. Biallelic RFC1 mutations were found in three patients with immune-mediated neuropathies, including Guillain-Barré syndrome, idiopathic sensory ataxic neuropathy, or anti-myelin-associated glycoprotein (MAG) neuropathy, who responded to immunotherapies. In addition, a patient with chronic sensory autonomic neuropathy had biallelic mutations, and subclinical changes in Schwann cells on nerve biopsy. In summary, we found CANVAS-related RFC1 mutations in patients with treatable immune-mediated neuropathy or demyelinating neuropathy.
Funder
Ministry of Education, Culture, Sports, Science and Technology
Kindai University Research Enchancement Grant
Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Ministry of Health, Labour and Welfare
Publisher
Springer Science and Business Media LLC
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献